Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02299141
Title Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

lung non-small cell carcinoma

Therapies

Nintedanib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST